This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Drug - induced testosterone deficiency (TD) in a male

Authoring team

Medications associated with an increased prevalence of TD

Medications associated with an increased prevalence of TD:1-5

  • oral glucocorticoids
  • opioids
  • antipsychotics
  • anticonvulsants
  • androgen deprivation therapy
  • antiretroviral therapy
  • chemotherapy + radiation
  • methadone maintenance therapy

References

  • 1. Khera M, Adaikan G, Buvat J, et al. Diagnosis and Treatment of Testosterone Deficiency: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015). J Sex Med 2016;13:1787-1804.
  • 2. Dohle GH, Arver S, Bettochi C et al. Guidelines on Male Hypogonadism. European Association of Urology 2017. Available at: http://uroweb.org/guideline/male-hypogonadism/ (Accessed May 2018).
  • 3. Bhasin S et al. Task Force, Endocrine Society. Testosterone therapy in men with androgen deficiency syndromes: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2010;95:2536-59.
  • 4. Lunenfeld B, Mskhalaya G, Zitzmann M, et al. Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men. Aging Male 2015;18:5-15.
  • 5. Hassan J, Barkin J. Testosterone deficiency syndrome: benefits, risks and realities associated with testosterone replacement therapy. Can J Urol 2016;23:20-30.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.